Accelerating recombinant protein vaccine discovery
Drug Discovery World
FEBRUARY 14, 2024
Especially for rapidly-mutating viruses (such as SARS-CoV-2), tools that can help inform the rapid development of vaccines are crucial in being better prepared for future health crises. Unlike other types of vaccines that use viral genetic codes or viral vectors, recombinant protein vaccines use only the antigenic proteins themselves.
Let's personalize your content